Skip to main content
Premium Trial:

Request an Annual Quote

The ARRA Opportunity

In the Chronicle of Higher Education, a commentary from three people at the Association of American Medical Colleges says that US stimulus act presents an "exceptional opportunity" for research and training and for growing the NIH budget. The authors write:

The Recovery Act's political significance for biomedical research goes far beyond material support, reflecting the trust of Congress and the administration in the medical and scientific communities as responsive and essential to long-term economic development and health.

Writedit at Medical Writing, Editing & Grantsmanship is skeptical. "If the impact ... turns out to be mediocre at best (at least in the short-fuse time span acceptable to elected representatives), and if Congress therefore feels justified in maintaining flat-lined federal spending, this would seem to be akin to basing the future of the US research enterprise on the outcome of a pop quiz," she writes.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.